Pemoline induced acute choreoathetosis: Case report and review of the literature

Journal of Toxicology - Clinical Toxicology

Volumn 35, Issue 1, 1997, Pages 105-108

  Stork, Christine M ^a   Cantor, Richard ^a  

^a University Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE DERIVATIVE; METHYLPHENIDATE; OXAZOLIDINE DERIVATIVE; PEMOLINE;

ARTICLE; ATTENTION DEFICIT DISORDER; CASE REPORT; CHILD; CHOREOATHETOSIS; DRUG INTOXICATION; HUMAN; MALE; MONOZYGOTIC TWINS; MOTOR DYSFUNCTION; ORAL DRUG ADMINISTRATION; SYMPTOMATOLOGY;

EID: 0031041996     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.3109/15563659709001175     Document Type: Article

References (22)

1. Elia J. Drug treatment for hyperactive children. Therapeutic guidelines. Drugs 1993;46:863-871.
2. Pelham WE, Greenslade KE, Vodde-Hamilton M, et al. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: A comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline. Pediatrics 1990;86:226-237.
3. Langer DH, Sweeney KP, Bartenbach DE, Davis PM, Menandu KB. Evidence of lack of abuse or dependence following pemoline treatment: Results of a retrospective survey. Drug Alcohol Depend 1986; 17:213-227.
4. Nehra A, Mullick F, Ishak KG, Zimmerman HJ. Pemoline-associated hepatic injury. Gastroenterology 1990;99:1517-1519.
5. Tolman KG, Freston JW, Berenson MM, Sannella JJ. Hepatotoxicity due to pemoline. Report of 2 cases. Digestion 1973;9:532-539.
6. Molina VA, Orsinger OA. Effects of Mg-pemoline on the central catecholaminergic system. Arch Int Pharmacodyn Ther 1981;251:66-79.
7. Gilbert JC, Allen JM, Townsend BG, Wyllie MG. Drugs affecting the central nervous system. Effects of pemoline ant tricyclic antidepressants on nerve terminal adenosine triphosphate activities and neurotransmitter release. Neuropharmacology 1978; 17:419-421.
8. Collier CP, Soldin SJ, Swanson JM, et al. Pemoline pharmacokinetics and long term therapy in children with attention deficit disorder and hyperactivity. Clin Pharmacokinet 1985;10:269-278.
9. Bonthala CM, West A. Pemoline induced chorea and Gilles de la Tourette's syndrome. Br J Psychiatry 1983;143:300-302.
10. Mitchell E, Matthews KL. Gilles de la Tourette's disorder associated with pemoline. Am J Psychiatry 1980;137:1618-1619.
11. McNeil JR. Accidental ingestion of pemoline. Clin Pediatr Phila 1979;18:761-762.
12. David T, Vale A. Pemoline poisoning. Arch Toxicol 1981;48:205-207.
13. Singh BK, Singh A, Chusid E. Chorea in long-term use of pemoline. Ann Neurol 1983;13:218.
14. Bachman DS. Pemoline-induced Tourette's disorder. A case report. Am J Psychiatry 1981;138:1116-1117.
15. Briscoe JG, Curry SC, Gerkin RD, Ruiz RR. Pemoline-induced choreoathetosis and rhabdomyolysis. Med Toxicol Adverse Drug Exp 1988;3:72-76.
16. Nausieda PA, Koller WC, Weiner WJ, Klawans HL. Pemoline-induced chorea. Neurology 1981;31:356-360.
17. Sperling LS, Horowitz JL. Metamphetamine-induced choreoathetosis and rhabdomyolysis. Ann Intern Med 1994;121:986.
18. Rhee KJ, Albertson TE, Douglas JC. Choreoatethoid disorder associated with amphetamine-like drugs. Am J Emerg Med 1988;6:131-133.
19. Lipkin PH, Goldstein JJ, Adesman AR. Tics and dyskinesias associated with stimulant treatment in attention deficit hyperactivity disorder. Arch Pediatr Adolesc Med 1994;148:859-861.
20. Sallee FR, Stiller RL, Perel JM, Everett G. Pemoline-induced abnormal involuntary movements. J Clin Psychopharmacol 1989;9:125-129.
21. Klawans HL, Weiner WJ. The pharmacology of choreatic movement disorders. Prog Neurobiol 1976;6:49-80.
22. Johansson P, Levin E, Gunne L, Ellison G. Opposite effects of a D1 and a D2 agonist on oral movements in rats. Eur J Pharmacol 1987;134:83-88.